Daryl T Y Lau1, Lilia Ganova-Raeva2, Junyao Wang3, Douglas Mogul4, Raymond T Chung5, Mauricio Lisker-Melman6, Kyong-Mi Chang7, Obaid S Shaikh8, Harry L A Janssen9, Abdus S Wahed3, Anna S Lok10. 1. Liver Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. 2. Division of Viral Hepatitis Laboratory Branch, Centers for Disease Control and Prevention, Atlanta, GA. 3. Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA. 4. Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD. 5. Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 6. Washington University School of Medicine, St. Louis, MO. 7. Medical Research, The Corporal Michael J. Crescenz VA Medical Center and Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 8. Division of Gastroenterology, VA Pittsburgh Healthcare System, Pittsburgh, PA. 9. Toronto Centre for Liver Disease, Toronto General Hospital, University of Toronto, Toronto, ON, Canada. 10. Department of Internal Medicine-Gastroenterology, University of Michigan, Ann Arbor, MI.
Abstract
BACKGROUND AND AIMS: Hepatitis B virus (HBV) precore (PC) and dual basal core promoter (BCP) mutations halt and down-regulate hepatitis B e antigen (HBeAg) production respectively. PC mutation is rarely associated with HBV genotype A. We sought to examine the association of these variants with HBV genotypes, age, and HBeAg status in a racially diverse population in North America. Prospective study included 1,036 (808 adults, 228 children) participants in the Hepatitis B Research Network. PC and BCP variants were determined by Sanger sequencing, and dominant HBV species (>50%) were reported. APPROACH AND RESULTS: Median age was 36.3 years (range, 2-80), 44.6% HBeAg(+), 74.2% Asians, 13.3% black, and 9.7% white. The dominant PC variant was present in 29.4% participants, including 20 with subgenotype A1 or A2. Seventeen of 20 participants with genotype A and PC had a compensatory C1858T mutation. In the HBeAg(+) cohort, the prevalence of PC and/or BCP variants increased from 14.4% in the first two decades to 51% after 40 years of age. Among those aged 2-18, 52% and 83% with dominant PC and BCP variants were HBeAg(+) compared to 3.8% and 29% in the >40 years age group. HBeAg clearance rates were significantly higher for those with dominant PC or BCP variants: 24.4 and 15.0 per 100 person-years compared to 6.0 in wild-type HBV (P < 0.0001). CONCLUSIONS: PC variants can be present in HBV genotype A and are usually associated with C1858T, which preserves the pregenome encapsidation sequence. Selection of PC and BCP variants occurred at a young age, with increasing prevalence across age groups. HBeAg(+) participants with dominant PC and BCP variants progressed to the HBeAg(-) phase of chronic HBV infection significantly faster. This finding has potential clinical and therapeutic implications.
BACKGROUND AND AIMS: Hepatitis B virus (HBV) precore (PC) and dual basal core promoter (BCP) mutations halt and down-regulate hepatitis B e antigen (HBeAg) production respectively. PC mutation is rarely associated with HBV genotype A. We sought to examine the association of these variants with HBV genotypes, age, and HBeAg status in a racially diverse population in North America. Prospective study included 1,036 (808 adults, 228 children) participants in the Hepatitis B Research Network. PC and BCP variants were determined by Sanger sequencing, and dominant HBV species (>50%) were reported. APPROACH AND RESULTS: Median age was 36.3 years (range, 2-80), 44.6% HBeAg(+), 74.2% Asians, 13.3% black, and 9.7% white. The dominant PC variant was present in 29.4% participants, including 20 with subgenotype A1 or A2. Seventeen of 20 participants with genotype A and PC had a compensatory C1858T mutation. In the HBeAg(+) cohort, the prevalence of PC and/or BCP variants increased from 14.4% in the first two decades to 51% after 40 years of age. Among those aged 2-18, 52% and 83% with dominant PC and BCP variants were HBeAg(+) compared to 3.8% and 29% in the >40 years age group. HBeAg clearance rates were significantly higher for those with dominant PC or BCP variants: 24.4 and 15.0 per 100 person-years compared to 6.0 in wild-type HBV (P < 0.0001). CONCLUSIONS: PC variants can be present in HBV genotype A and are usually associated with C1858T, which preserves the pregenome encapsidation sequence. Selection of PC and BCP variants occurred at a young age, with increasing prevalence across age groups. HBeAg(+) participants with dominant PC and BCP variants progressed to the HBeAg(-) phase of chronic HBV infection significantly faster. This finding has potential clinical and therapeutic implications.
Authors: M S De Mitri; R Cassini; G Morsica; S Bagaglio; P Andreone; E Loggi; P Muratori; M Bernardi Journal: J Viral Hepat Date: 2006-09 Impact factor: 3.728
Authors: Chi-Jen Chu; Emmet B Keeffe; Steven-Huy Han; Robert P Perrillo; Albert D Min; Consuelo Soldevila-Pico; William Carey; Robert S Brown; Velimir A Luketic; Norah Terrault; Anna S F Lok Journal: Hepatology Date: 2003-09 Impact factor: 17.425
Authors: Elizabeth G Bannister; Lilly Yuen; Margaret Littlejohn; Rosalind Edwards; Vitina Sozzi; Danni Colledge; Xin Li; Stephen Locarnini; Winita Hardikar; Peter A Revill Journal: J Gen Virol Date: 2018-06-22 Impact factor: 3.891
Authors: Norah A Terrault; Abdus S Wahed; Jordan J Feld; Stewart L Cooper; Mark G Ghany; Mauricio Lisker-Melman; Robert Perrillo; Richard K Sterling; Mandana Khalili; Raymond T Chung; Philip Rosenthal; Robert J Fontana; Arif Sarowar; Daryl T Y Lau; Junyao Wang; Anna S Lok; Harry L A Janssen Journal: Hepatology Date: 2022-01-26 Impact factor: 17.425
Authors: William M Lee; Wendy C King; Harry L A Janssen; Marc G Ghany; Robert J Fontana; Michael Fried; Richard K Sterling; Jordan J Feld; Junyao Wang; Douglas B Mogul; Stewart L Cooper; Adrian M Di Bisceglie Journal: J Viral Hepat Date: 2021-08-11 Impact factor: 3.728